Latest Medx Health Corp (MDXHF) Headlines Med
Post# of 4
Posted On: 03/10/2014 1:20:56 PM
Latest Medx Health Corp (MDXHF) Headlines
MedX Health Corp. Announces CE Mark for Its MOLEMATE(TM)/SIMSYS(TM) Skin Cancer Imaging Systems
Marketwire - Wed Feb 12, 10:50AM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), a leader in skin cancer imaging and diagnostics, announced receipt of a CE Mark from Conformite Europeenne, which allows the Company to market its MoleMate and SIMSYS systems in Europe to dermatologists and to expand further its pharmacy-based sales channel.
MedX Health Corp. Announces Brokered Private Placement
Marketwire - Wed Jan 22, 9:19AM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces the engagement of Trapeze Capital Corp., as lead agent (the "Agent"), to raise gross proceeds of up to $2.0 million, from accredited investors, on a reasonable efforts basis through a private placement of Units, with each Unit comprised of one Common Share and one Common Share Purchase Warrant ('Warrant") (the "Offering") at $0.10 per Unit. Each Warrant will entitle the holder to purchase one Common Share during the period ending two years from the date of issue, at an exercise price of $0.20.
MedX Health Corp. Announces Closing of Private Placement and Debt Settlements
Marketwire - Tue Dec 31, 5:03PM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces that it has closed on a private placement, as announced on December 20, 2013, to raise $203,000 by the issuance of 2,030,000 units, comprising 2,030,000 common shares and 2,030,000 share purchase warrants ("Warrants") at $0.10 per unit. Each Warrant entitles the holder to purchase one additional common share during the period expiring December 31, 2014, at $0.20 per share. The securities issued through the private placement were subscribed for by accredited investors, and are restricted from trading before May 1, 2014.
MedX Health Corp. Announces Proposed Private Placement to Raise $203,000
Marketwire - Fri Dec 20, 3:36PM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces that it has entered into private placement agreements with accredited investors to raise a total of $203,000 by issuance of a total of 2,030,000 Units at $0.10 per unit. Each Unit comprises one fully paid common share and one share purchase warrant; each warrant entitles the holder to purchase one additional share at the price of $0.20 during the period expiring December 31, 2014. Closing of the Placement is subject to all relevant regulatory and other consents and approvals, including acceptance by the TSX Venture Exchange.
MedX Health Corp. Announces Executive Changes
Marketwire - Fri Nov 29, 3:02PM CST
The Board of Directors of MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce the following Senior Executive changes.
MedX Health Corp. Results for the Third Quarter of Fiscal 2013
CNW Group - Tue Nov 12, 8:23PM CST
TSX Venture Symbol: MDX
MedX Health Corp. Announces Proposed Debt Settlements and Private Placement
CNW Group - Tue Oct 29, 7:20AM CDT
MedX Health Corp. (TSX-V - MDX), announces that it has entered into agreements to settle a total of $1,779,933 of debt owed to certain trade creditors, general creditors and insider creditors, subject to all relevant consents and approvals. Under the Debt Settlement Agreements, a total of $179,708 of trade debt will be settled by issuance of 898,812 shares issued at $0.20 per share, $1,164,620 of debt due to general creditors will be settled by issuance of 11,646,204 units at $0.10 per unit, and $435,603 of debt due to insider creditors will be settled by issuance of 1,742,415 shares at $0.25 per share. Each of the units proposed to be issued to general creditors will be comprised of one fully paid common share and one-half of a share purchase warrant; each whole warrant will be exercisable to purchase one common share at $0.20 per share for the period to December 31, 2014, and at $0.30 from January 1, 2015 to December 31, 2015. Regulatory and other consents will include approval from the TSX Venture Exchange and, in relation to shares issuable to insiders, approval of shareholders (excluding votes of shares owned by the relevant insiders).
MedX Health Corp. results for the Second Quarter of fiscal 2013
CNW Group - Tue Aug 27, 10:06PM CDT
TSX Venture Symbol: MDX
MedX Health Corp. Announces Share Issuance Pursuant To Debt Settlement Agreements And Also Grant Of Stock Options
CNW Group - Fri Jul 19, 3:51PM CDT
TSX Venture Symbol: MDX
MedX Health Corp. reaches agreements to settle debts of $362,078
CNW Group - Thu Jul 04, 2:23PM CDT
TSX Venture Symbol: MDX CUSIP #: 585090
MedX Health Reports 2012 and First Quarter 2013 Financial Results
CNW Group - Fri Jun 07, 11:29AM CDT
MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser light therapy for tissue repair and pain relief have reported their revenues for 2012 and the first quarter of 2013. Please see www.SEDAR.com for the actual filings.
IIROC Trading Resumption - MDX
CNW Group - Fri May 31, 3:27PM CDT
Trading resumes in:
IIROC: Resume, OREMEX SILVER INC., MEDX HEALTH CORP.
Marketwire Canada - Fri May 31, 3:25PM CDT
Trading resumes in / Reprise des negociations pour :
IIROC Trade Resumption - MedX Health Corp.
Newsfile Corp - Fri May 31, 3:15PM CDT
Trading resumes in:
TSX Venture Exchange: Cease Trade Order, Acadian Energy Inc., PharmaGap Inc., Intellectual Capital Group Ltd., MedX Health Corp.
Marketwire Canada - Mon May 06, 12:30PM CDT
BULLETIN TYPE: Cease Trade Orders
MedX Health Corp. Announces CE Mark for Its MOLEMATE(TM)/SIMSYS(TM) Skin Cancer Imaging Systems
Marketwire - Wed Feb 12, 10:50AM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX), a leader in skin cancer imaging and diagnostics, announced receipt of a CE Mark from Conformite Europeenne, which allows the Company to market its MoleMate and SIMSYS systems in Europe to dermatologists and to expand further its pharmacy-based sales channel.
MedX Health Corp. Announces Brokered Private Placement
Marketwire - Wed Jan 22, 9:19AM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces the engagement of Trapeze Capital Corp., as lead agent (the "Agent"), to raise gross proceeds of up to $2.0 million, from accredited investors, on a reasonable efforts basis through a private placement of Units, with each Unit comprised of one Common Share and one Common Share Purchase Warrant ('Warrant") (the "Offering") at $0.10 per Unit. Each Warrant will entitle the holder to purchase one Common Share during the period ending two years from the date of issue, at an exercise price of $0.20.
MedX Health Corp. Announces Closing of Private Placement and Debt Settlements
Marketwire - Tue Dec 31, 5:03PM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces that it has closed on a private placement, as announced on December 20, 2013, to raise $203,000 by the issuance of 2,030,000 units, comprising 2,030,000 common shares and 2,030,000 share purchase warrants ("Warrants") at $0.10 per unit. Each Warrant entitles the holder to purchase one additional common share during the period expiring December 31, 2014, at $0.20 per share. The securities issued through the private placement were subscribed for by accredited investors, and are restricted from trading before May 1, 2014.
MedX Health Corp. Announces Proposed Private Placement to Raise $203,000
Marketwire - Fri Dec 20, 3:36PM CST
MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) announces that it has entered into private placement agreements with accredited investors to raise a total of $203,000 by issuance of a total of 2,030,000 Units at $0.10 per unit. Each Unit comprises one fully paid common share and one share purchase warrant; each warrant entitles the holder to purchase one additional share at the price of $0.20 during the period expiring December 31, 2014. Closing of the Placement is subject to all relevant regulatory and other consents and approvals, including acceptance by the TSX Venture Exchange.
MedX Health Corp. Announces Executive Changes
Marketwire - Fri Nov 29, 3:02PM CST
The Board of Directors of MedX Health Corp. ("MedX" or the "Company") (TSX VENTURE: MDX) is pleased to announce the following Senior Executive changes.
MedX Health Corp. Results for the Third Quarter of Fiscal 2013
CNW Group - Tue Nov 12, 8:23PM CST
TSX Venture Symbol: MDX
MedX Health Corp. Announces Proposed Debt Settlements and Private Placement
CNW Group - Tue Oct 29, 7:20AM CDT
MedX Health Corp. (TSX-V - MDX), announces that it has entered into agreements to settle a total of $1,779,933 of debt owed to certain trade creditors, general creditors and insider creditors, subject to all relevant consents and approvals. Under the Debt Settlement Agreements, a total of $179,708 of trade debt will be settled by issuance of 898,812 shares issued at $0.20 per share, $1,164,620 of debt due to general creditors will be settled by issuance of 11,646,204 units at $0.10 per unit, and $435,603 of debt due to insider creditors will be settled by issuance of 1,742,415 shares at $0.25 per share. Each of the units proposed to be issued to general creditors will be comprised of one fully paid common share and one-half of a share purchase warrant; each whole warrant will be exercisable to purchase one common share at $0.20 per share for the period to December 31, 2014, and at $0.30 from January 1, 2015 to December 31, 2015. Regulatory and other consents will include approval from the TSX Venture Exchange and, in relation to shares issuable to insiders, approval of shareholders (excluding votes of shares owned by the relevant insiders).
MedX Health Corp. results for the Second Quarter of fiscal 2013
CNW Group - Tue Aug 27, 10:06PM CDT
TSX Venture Symbol: MDX
MedX Health Corp. Announces Share Issuance Pursuant To Debt Settlement Agreements And Also Grant Of Stock Options
CNW Group - Fri Jul 19, 3:51PM CDT
TSX Venture Symbol: MDX
MedX Health Corp. reaches agreements to settle debts of $362,078
CNW Group - Thu Jul 04, 2:23PM CDT
TSX Venture Symbol: MDX CUSIP #: 585090
MedX Health Reports 2012 and First Quarter 2013 Financial Results
CNW Group - Fri Jun 07, 11:29AM CDT
MedX Health Corp., (TSXV.MDX) a global leader in drug free, non-invasive low level laser light therapy for tissue repair and pain relief have reported their revenues for 2012 and the first quarter of 2013. Please see www.SEDAR.com for the actual filings.
IIROC Trading Resumption - MDX
CNW Group - Fri May 31, 3:27PM CDT
Trading resumes in:
IIROC: Resume, OREMEX SILVER INC., MEDX HEALTH CORP.
Marketwire Canada - Fri May 31, 3:25PM CDT
Trading resumes in / Reprise des negociations pour :
IIROC Trade Resumption - MedX Health Corp.
Newsfile Corp - Fri May 31, 3:15PM CDT
Trading resumes in:
TSX Venture Exchange: Cease Trade Order, Acadian Energy Inc., PharmaGap Inc., Intellectual Capital Group Ltd., MedX Health Corp.
Marketwire Canada - Mon May 06, 12:30PM CDT
BULLETIN TYPE: Cease Trade Orders
(0)
(0)Medx Health Corp (MDXHF) Stock Research Links
Scroll down for more posts ▼